The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)

by Wittkowski, H, Kallinich, T, Keitzer, R, Roth, J, Foell, D
Published 2008

Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany

by Ayaz, N Aktay, Özen, S, Lainka, E, Taskiran, E, Duzova, A, Besbas, N, Bakkaloglu, A, Kallinich, T
Published 2008

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany

by Gohar, F, Jeske, M, Lohse, P, Kallinich, T, Neudorf, U, Niehues, T, Wittkowski, H, Lainka, E, Foell, D
Published 2013

PW03-025 - Procaspase-1 contributes to inflammation via NF-KB

by Heymann, M, Winkler, S, Özen, S, Yilmaz, E, Kallinich, T, Rösen-Wolff, A, Roesler, J, Hofmann, S
Published 2013

PW01-008 – The inflammasome and secretory pathways in FMF

by Orak, B, Kallinich, T, Lieber, M, von Bernuth, H, Wittkowski, H, Foell, D
Published 2013

Colchicine therapy in children with FMF

by Knieper, A-M, Klotsche, J, Föll, D, Wittkowski, H, Lainka, E, Kallinich, T
Published 2015

Impact of hereditary periodic fever syndromes and its change over time

by Niewerth, M, Kallinich, T, Hospach, A, Behrendes, R, Thon, A, Minden, K
Published 2015

Expression of ICOS In Vivo Defines CD4+ Effector T Cells with High Inflammatory Potential and a Strong Bias for Secretion of Interleukin 10

by Löhning, Max, Hutloff, Andreas, Kallinich, Tilmann, Mages, Hans Werner, Bonhagen, Kerstin, Radbruch, Andreas, Hamelmann, Eckard, Kroczek, Richard A.
Published 2003

PReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register

by Gohar, F, Husmann, E, Haas, PJ, Horneff, G, Wittkowski, H, Holzinger, D, Kallinich, T, Neudorf, U, Niehues, T, Lainka, E, Foell, D
Published 2013

Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course

by Kallinich, Tilmann, Thorwarth, Anne, von Stuckrad, Sae-Lim, Rösen-Wolff, Angela, Luksch, Hella, Hundsdoerfer, Patrick, Minden, Kirsten, Krawitz, Peter
Published 2016

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients

by Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schütz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Published 2013

PW02-041 - Canakinumab treatment regimens in CAPS-patients

by Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Published 2013

Canakinumab treat-to target strategies increase complete response rate in CAPS

by Kuemmerle-Deschner, J, Hofer, F, Endres, T, Kortus-Goetze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Benseler, SM
Published 2015

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

by Ruperto, N, Brunner, H, Horneff, G, Quartier, P, Constantin, T, Berkun, Y, Erguven, M, Kallinich, T, Brik, R, Wulffraat, NM, Ferrandiz, MA, Rutkowska-Sak, L, Ozdogan, H, McCann, L, Lheritier, K, Preiss, R, Tseng, L, Martini, A, Lovell, DJ
Published 2011

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

by Quartier, P, Brunner, H, Constantin, T, Padeh, S, Calvo, I, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Oliveira, S, Uziel, Y, Viola, S, Nistala, K, Wouters, C, Lheritier, K, Hruska, J, Abrams, K, Martini, A, Ruperto, N, Lovell, D
Published 2013

P01-008 – FMF genotype-phenotype correlations in Germany

by Jeske, M, Lohse, P, Kallinich, T, Berger, T, Rietschel, C, Holzinger, D, Kamlah, C, Lankisch, P, Berendes, R, Dückers, G, Horneff, G, Lilienthal, E, Haas, JP, Giese, A, Dressler, F, Berrang, J, Pütter, C, Braunewell, L, Neudorf, U, Niehues, T, Lainka, E
Published 2013

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)

by M. Bielak, E. Husmann, N. Weyandt, J.-P. Haas, B. Hügle, G. Horneff, U. Neudorf, T. Lutz, E. Lilienthal, T. Kallinich, K. Tenbrock, R. Berendes, T. Niehues, H. Wittkowski, E. Weißbarth-Riedel, G. Heubner, P. Oommen, J. Klotsche, Dirk Foell, E. Lainka
Published 2018-04-01

Interleukin (IL)- 6 inhibition - Follow-up data of the German AID-registry1

by Bielak, M, Husmann, E, Weyandt, N, Haas, JP, Horneff, G, Lutz, T, Lilienthal, E, Kallinich, T, Tenbrock, K, Berendes, R, Dückers, G, Wittkowski, H, Weißbarth-Riedel, E, Heubner, G, Oommen, PT, Klotsche, J, Neudorf, U, Föll, D, Niehues, T, Lainka, E
Published 2015

Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

by Quartier, P, Grom, A, Ruperto, N, Brunner, HI, Schikler, K, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Marzan, K, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, DJ
Published 2014

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis

by Preuße, Corinna, Allenbach, Yves, Hoffmann, Olaf, Goebel, Hans-Hilmar, Pehl, Debora, Radke, Josefine, Doeser, Alexandra, Schneider, Udo, Alten, Rieke H.E., Kallinich, Tilmann, Benveniste, Olivier, von Moers, Arpad, Schoser, Benedikt, Schara, Ulrike, Stenzel, Werner
Published 2016